Other cancer immunotherapies have included immunostimulatory cytokines such as IL-2 and IFN-α [106, 107], as well as antibodies against tumor antigens [108–110], for use as adjuvants in combination with chemotherapy or cancer vaccines. This evidence concerns the gene IL2 and cancer.